|
시장보고서
상품코드
2039043
경구용 스마트 알약 시장 : 컴포넌트별, 용도별, 최종사용자별, 지역별Ingestible Smart Pills Market, By Component, By Application, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
경구용 스마트 알약 시장은 2026년에 16억 달러로 추정되며, 2033년까지 23억 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR은 5.6%를 보일 전망입니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 16억 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR | 5.60% | 예측 금액(2033년) | 23억 달러 |
스마트 알약은 센서, 카메라, 패치, 추적기 등이 내장된 소형 전자기기입니다. 이 알약을 삼키면 소화관의 완전한 진단 평가를 할 수 있습니다. 스마트 알약은 질병의 비침습적 진단을 가능하게 하고, 환자의 복약 순응도와 만족도를 높이는 등 여러 가지 장점을 가지고 있습니다.
세계 경구용 스마트 알약 시장 성장 억제요인.
예측 기간 동안 경구용 스마트 알약 시장의 성장을 저해하는 주요 요인으로는 치료제의 효능 비교에 대한 연구가 제한적이며, 제조 공정의 문제 등이 있습니다.
본 보고서의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한, 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
- 세계 경구용 스마트 알약 시장의 주요 기업 프로파일을 기업 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등의 매개 변수를 기반으로 정리하여 전해드립니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- '세계 경구용 스마트 알약 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 경구용 스마트 알약 시장 : 컴포넌트별(2021년-2033년)
제5장 세계의 경구용 스마트 알약 시장 : 용도별(2021년-2033년)
제6장 세계의 경구용 스마트 알약 시장 : 최종사용자별(2021년-2033년)
제7장 세계의 경구용 스마트 알약 시장 : 지역별(2021년-2033년)
제8장 경쟁 구도
제9장 섹션
LSH 26.06.04Ingestible Smart Pills Market is estimated to be valued at USD 1.6 Bn in 2026 and is expected to reach USD 2.3 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1.6 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.60% | 2033 Value Projection: | USD 2.3 Bn |
Smart pills are small embedded electronic devices, which include sensors, cameras, patches and trackers. These pills are capable of providing complete diagnostic evaluation of the gastrointestinal tract when swallowed. There are several advantages of smart pills such as it enables noninvasive diagnosis of diseases, and patient adherence and satisfaction.
Restraints of the Global Ingestible Smart Pills Market
Major factors hampering the growth of the ingestible smart pills market during the forecast period constitutes of limited studies on efficacy comparison of treating agents, and challenging manufacturing process.
Key features of the study
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
- It profiles leading players in the global ingestible smart pills market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include BodyCap Medical, Given Imaging Ltd., Olympus Corporation, Proteus Digital Health, Inc., CapsoVision, Inc., Chongqing Jinshan Science and Component (Group) Co., Ltd., Medimetrics, IntroMedic Co., Ltd., Check-Cap Ltd., Boston Scientific Corporation, HQ Inc., Smart Pill Inc., Medtronic plc, Philips Healthcare, etectRx, Inc., Novartis, Siemens Healthcare, Pentax Medical Company (HOYA Corporation), GE Healthcare, and Stryker Corporation.
- Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
- The global ingestible smart pills market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Market Segmentation
- Global Ingestible Smart Pills Market, By Component (Revenue, USD Bn, 2021-2033)
- Smart Pills
- Patient Monitoring
- Capsule Endoscopy
- Small Bowel Endoscopy
- Esophagus Endoscopy
- Colon Endoscopy
- Workstation
- Global Ingestible Smart Pills Market, By Application (Revenue, USD Bn, 2021-2033)
- Imaging
- Monitoring
- Global Ingestible Smart Pills Market, By End User (Revenue, USD Bn, 2021-2033)
- Hospitals
- Clinics
- Research Institutes
- Home Healthcare
- Global Ingestible Smart Pills Market, By Regions (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
- Key Players
- BodyCap Medical
- Given Imaging Ltd.
- Olympus Corporation
- Proteus Digital Health, Inc.
- CapsoVision, Inc.
- Chongqing Jinshan Science and Component (Group) Co., Ltd.
- Medimetrics
- IntroMedic Co., Ltd.
- Check-Cap Ltd.
- Boston Scientific Corporation
- HQ Inc.
- Smart Pill Inc.
- Medtronic plc
- Philips Healthcare
- etectRx, Inc.
- Novartis
- Siemens Healthcare
- Pentax Medical Company (HOYA Corporation)
- GE Healthcare
- Stryker Corporation
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Component
- Market Snippet, By Application
- Market Snippet, By End User
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Regulatory Scenario
- PEST Analysis
4. Global Ingestible Smart Pills Market, By Component, 2021 - 2033 (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Smart Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Patient Monitoring
- Capsule Endoscopy
- Small Bowel Endoscopy
- Esophagus Endoscopy
- Colon Endoscopy
- Workstation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
5. Global Ingestible Smart Pills Market, By Application, 2021 - 2033 (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
6. Global Ingestible Smart Pills Market, By End User, 2021 - 2033 (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Home Healthcare
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
7. Global Ingestible Smart Pills Market, By Regions, 2021 - 2033 (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- BodyCap Medical
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Given Imaging Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Olympus Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Proteus Digital Health, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CapsoVision, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Chongqing Jinshan Science and Component (Group) Co., Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medimetrics
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- IntroMedic Co., Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Check-Cap Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HQ Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Smart Pill Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic plc
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Philips Healthcare
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- etectRx, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthcare
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pentax Medical Company (HOYA Corporation)
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GE Healthcare
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Stryker Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BodyCap Medical
9. Section
- References
- Research Methodology
- About us and Sales Contact
